News | October 30, 2006

TomoTherapy Installs 100th Hi-Art System

TomoTherapy announced today that it has installed its 100th Hi-Art System in Stratton VA Medical Center, as part of Stratton VA’s efforts to be the first government facility to offer TomoTherapy radiation treatments to U.S. veterans.
The TomoTherapy Hi-Art System is designed to target radiation treatment to the patient’s tumor while helping to limit damage to the surrounding tissues. The system combines on-board CT imaging with conformal radiation therapy to provide precision in the treatment of cancer patients.

Related Content

New partnership makes outstanding radiation protection solutions available to healthcare professionals
News | Radiation Dose Management
BIOTRONIK and Texray Establish Collaboration to Distribute Texray’s Innovative Radiation Protection Products

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
In survey of more than 200 U.S. oncologists, vast majority indicate that oncologists should be able to explain how AI works to their patients
News | Artificial Intelligence
Study Provides a First Look at Oncologists' Views on Ethical Implications of AI in Cancer Care

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
Minimally invasive procedure provides disease control without devastating side effects
News | Prostate Cancer
New Treatment Option for Prostate Cancer Shows Successful Outcomes

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology
VIDEO: Advancements and New Technology in Diagnostic Radiology to Help in the Fight Against Cancer

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
As part of this grant, Breast Acoustic CT (ACT) quantitative images with independent biomarkers known to be sensitive to cancer will be collected, and the response of cancer to therapy, will be derived from quantitative ultrasound based on backscatter analysis
News | Breast Imaging
QT Imaging’s Breast Acoustic CT Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Addressing actionable insights into opportunities, challenges, legal and regulatory issues, an expert panel offers essential considerations for radiation oncologists using artificial intelligence in clinical practice
Feature | Radiation Oncology | By Christine Book
Practical Considerations for the Use of Artificial Intelligence in Radiation Oncology

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
HyperSight is designed to enhance accuracy in delivering radiotherapy treatments, with the goal of effective protection of healthy tissues
News | FDA
Varian Receives FDA 510(k) Clearance for TrueBeam and Edge Radiotherapy Systems Featuring HyperSight Imaging Solution

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
Telemedicine industry veterans launch new venture to support health care providers and address the radiologist shortage
News | Breast Imaging
Whole Breast Ultrafractionation Radiotherapy After Breast-conserving Surgery in Early Breast Cancer had No Severe Toxicities and Did Not Affect Patient-reported Outcome

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
Clinical trials will assess multi-cancer detection tests, among others
News | Radiation Oncology
NIH Launches Research Network to Evaluate Emerging Cancer Screening Technologies

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is a center of excellence and recognized leader in the treatment of cancer in the province of Quebec
News | Radiation Oncology
Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact System

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now